Moderna Cancer Vaccine Data Confirms 42% Recurrence Cut
Moderna cancer vaccine data confirms a 42% cut in melanoma recurrence risk, but an ESMO embargo breach triggered wild swings in MRNA shares.
Topic
clinical trials
Every Financial News story tagged clinical trials, newest first.
- Stories
- 11
- Last updated
- Follow
- RSS feed
Moderna stock plunges 25% after melanoma vaccine data leak
A melanoma vaccine data leak wiped $24bn off Moderna before its Madrid presentation, despite a statistically strong Phase 3 result.
Gilead’s UC Pill Hits Trial Goal, Stock Still Slips
Gilead's ulcerative colitis trial met its main goal, but GILD shares fell 1.42% as RBC said the readout was unlikely to move…
More in clinical trials
1–10 of 11
Adlai Nortye lines up Lilly, Merck KGaA for AN4035 trial
Adlai Nortye clinical collaboration with Lilly and Merck KGaA will test AN4035 plus cetuximab, as ANL shares trade 26% below their 20-day high.
BMY’s admilparant hits IPF trial goal, but only at lower dose
Bristol Myers Squibb's admilparant Phase 3 trial met its primary endpoint in IPF, but only the 60mg dose reached significance, filings show.
Pfizer’s tilrekimig hits Phase 2 goal, moves to Phase 3 trials
Pfizer's tilrekimig Phase 2 atopic dermatitis trial hit its primary endpoint, with the drug now advancing into Phase 3 studies in two indications.
Amgen’s dazodalibep Phase 3 trial clears Sjögren’s hurdle
Amgen's dazodalibep Phase 3 trial met its primary endpoint in systemic Sjögren's disease, sending AMGN shares higher on 22 September 2026.
London Ranks as Europe’s Leading Life Sciences Hub
London has emerged as the top European city for life sciences, securing the third spot globally.This recognition comes from a MedCity report highlighting the city's innovative research environment.London surpasses major…
Purespring Therapeutics Secures £80M to Advance Kidney Gene Therapies
Purespring Therapeutics, a pioneering biotech firm, has successfully raised £80 million. This funding marks a significant milestone in developing innovative gene therapies for kidney diseases.As kidney diseases continue to pose…
Rivia Secures €3M to Enhance AI in Clinical Trials
Swiss startup Rivia has emerged as a frontrunner in AI-driven clinical trial analytics, securing €3 million in funding. This development positions the company to lead innovation in biopharma analytics.The investment,…
Page 1 of 2